慢性肾脏病患者妊娠的管理现状及策略

doi:10.16150/j.1671-2870.2021.02.002

摘要/Abstract

中图分类号:

R692

杨聚荣, 林利容. 慢性肾脏病患者妊娠的管理现状及策略[J]. 诊断学理论与实践, 2021, 20(02): 125-129.

参考文献 45

[1]	Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818):815-822. doi: 10.1016/S0140-6736(12)60033-6 URL
[2]	Piccoli GB, Zakharova E, Attini R, et al. Pregnancy in chronic kidney disease: need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases[J]. J Clin Med, 2018, 7(11):415. doi: 10.3390/jcm7110415 URL
[3]	Shahir AK, Briggs N, Katsoulis J, et al. An observational outcomes study from 1966-2008, examining pregnancy and neonatal outcomes from dialysed women using data from the ANZDATA Registry[J]. Nephrology (Carlton), 2013, 18(4):276-84. doi: 10.1111/nep.12044 URL
[4]	Piccoli G, Bontempo S, Mezza E, et al. Sudden development of low tolerance of dialysis in a young female patient[J]. Nephrol Dial Transplant, 2004, 19(1):255-257. doi: 10.1093/ndt/gfg517 URL
[5]	Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy[J]. J Nephrol, 2016, 29(3)277-303. doi: 10.1007/s40620-016-0285-6 URL
[6]	南京总医院, 国家肾脏疾病临床医学研究中心. 慢性肾脏病患者妊娠管理指南[J]. 中华医学杂志, 2017, 97(46):3604-3612.
[7]	Masafumi F, Keitaro Y, Fumihiko K, et al. Clinical practice guideline for the management of chronic kidney disea-se-mineral and bone disorder[J/OL].(2012-05-23). https://cdn.jsn.or.jp/data/jsn-pregnancy.pdf.
[8]	de Castro I, Easterling TR, Bansal N, et al. Nephrotic syndrome in pregnancy poses risks with both maternal and fetal complications[J]. Kidney Int, 2017, 91(6):1464-1472. doi: S0085-2538(17)30003-0 pmid: 28233609
[9]	Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study[J]. J Autoimmun, 2016, 74:194-200. doi: 10.1016/j.jaut.2016.06.012 URL
[10]	Fredi M, Lazzaroni MG, Tani C, et al. Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies[J]. Autoimmun Rev, 2015, 14(8):686-691. doi: 10.1016/j.autrev.2015.03.009 URL
[11]	Buyon JP, Kim MY, Guerra MM, et al. Predictors of pregnancy outcomes in patients with lupus: a cohort study[J]. Ann Intern Med, 2015, 163(3):153-163. doi: 10.7326/M14-2235 pmid: 26098843
[12]	Zhou H, Liu Y, Liu L, et al. Maternal pre-pregnancy risk factors for miscarriage from a prevention perspective: a cohort study in China[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 206:57-63. doi: 10.1016/j.ejogrb.2016.07.514 URL
[13]	Nobles CJ, Mendola P, Mumford SL, et al. Pressure levels and reproductive outcomes in a prospective cohort of women attempting pregnancy[J]. Hypertension, 2018, 71(5):904-910. doi: 10.1161/HYPERTENSIONAHA.117.10705 URL
[14]	Wiles K, Chappell L, Clark K, et al. Clinical practice guideline on pregnancy and renal disease[J]. BMC Nephrol, 2019, 31, 20(1):401.
[15]	Harel Z, McArthur E, Hladunewich M, et al. Serum creatinine levels before, during, and after pregnancy[J]. JAMA, 2019, 321(2):205-207. doi: 10.1001/jama.2018.17948 pmid: 30644975
[16]	Wiles K, Bramham K, Seed PT, et al. Serum creatinine in pregnancy: a systematic review[J]. Kidney Int Rep, 2018, 4(3):408-419.
[17]	Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy[J]. Scand J Clin Lab Invest, 2002, 62(2):141-147. doi: 10.1080/003655102753611771 URL
[18]	Bramham K, Makanjuola D, Hussein W, et al. Serum cystatin is not a marker of glomerular filtration rate in pregnancy[J]. Obstet Med, 2009, 2(3):121-122. doi: 10.1258/om.2009.090019 URL
[19]	Piccoli GB, Cabiddu G, Attini R, et al. Risk of adverse pregnancy outcomes in women with CKD[J]. J Am Soc Nephrol, 2015, 26(8):2011-2022. doi: 10.1681/ASN.2014050459 URL
[20]	Maynard SE, Thadhani R. Pregnancy and the kidney[J]. J Am Soc Nephrol, 2009, 20(1):14-22. doi: 10.1681/ASN.2008050493 pmid: 19118150
[21]	Waugh JJ, Bell SC, Kilby MD, et al. Optimal bedside urinalysis for the detection of proteinuria in hypertensive pregnancy: a study of diagnostic accuracy[J]. BJOG, 2005, 112(4):412-417. doi: 10.1111/j.1471-0528.2004.00455.x URL
[22]	Huang Q, Gao Y, Yu Y, et al. Urinary spot albumin:creatinine ratio for documenting proteinuria in women with preeclampsia[J]. Rev Obstet Gynecol, 2012, 5(1):9-15.
[23]	Waugh J, Hooper R, Lamb E, et al. Spot protein-creatinine ratio and spot albumin-creatinine ratio in the assessment of pre-eclampsia: a diagnostic accuracy study with decision-analytic model-based economic evaluation and acceptability analysis[J]. Health Technol Assess, 2017, 21(61):1-90.
[24]	Wiles K, Webster P, Seed PT, et al. The impact of chronic kidney disease stages 3-5 on pregnancy outcomes[J]. Nephrol Dial Transplant, 2020, 12:1-10. doi: 10.1093/ndt/12.1.1 URL
[25]	陈洪, 周春华. 慢性肾脏病与妊娠[J]. 中华肾病研究电子杂志, 2018, 7(6):225-228.
[26]	Piccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review[J]. BJOG, 2013, 120(4):412-427. doi: 10.1111/1471-0528.12111 URL
[27]	Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy[J]. N Engl J Med, 2015, 372 (5):407-417. doi: 10.1056/NEJMoa1404595 URL
[28]	中华医学会妇产科学分会, 妊娠期高血压疾病学组. 妊娠期高血压疾病诊治指南(2020)[J]. 中华妇产科杂志, 2020, 55(4):227-238.
[29]	Brown MA, Magee LA, Kenny LC, et al. Hypertension in pregnancy(ISSHP). The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice[J]. Pregnancy Hypertens, 2018, 13:291-310. doi: S2210-7789(18)30126-0 pmid: 29803330
[30]	Bateman BT, Patorno E, Desai RJ, et al. Angiotensin-converting enzyme inhibitors and the risk of congenital malformations[J]. Obstet Gynecol, 2017, 129(1):174-184. doi: 10.1097/AOG.0000000000001775 pmid: 27926639
[31]	Bateman BT, Patorno E, Desai RJ, et al. Late pregnancy β blocker exposure and risks of neonatal hypoglycemia and bradycardia[J]. Pediatrics, 2016, 138:e20160731. doi: 10.1542/peds.2016-0731 URL
[32]	Morgan JL, Kogutt BK, Meek C, et al. Pharmacokinetics of amlodipine besylate at delivery and during lactation[J]. Pregnancy Hypertens, 2018, 11:77-80. doi: S2210-7789(17)30295-7 pmid: 29523279
[33]	Bergman JEH, Lutke LR, Gans ROB, et al. Beta-blocker use in pregnancy and risk of specific congenital anomalies: a european case-malformed control study[J]. Drug Saf, 2018, 41(4):415-427. doi: 10.1007/s40264-017-0627-x URL
[34]	Hviid A, Mølgaard-Nielsen D. Corticosteroid use during pregnancy and risk of orofacial clefts[J]. CMAJ, 2011, 183(7):796-804. doi: 10.1503/cmaj.101063 URL
[35]	Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study[J]. J Autoimmun, 2016, 74:6-12. doi: 10.1016/j.jaut.2016.07.010 URL
[36]	Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology (Oxford), 2016, 55(9):1693-1697. doi: 10.1093/rheumatology/kev404 URL
[37]	Chakkera HA, Kudva Y, Kaplan B. Calcineurin inhibitors: pharmacologic mechanisms impacting both insulin resistance and insulin secretion leading to glucose dysregulation and diabetes mellitus[J]. Clin Pharmacol Ther, 2017, 101(1):114-120. doi: 10.1002/cpt.546 pmid: 27804122
[38]	Kim H, Jeong JC, Yang J, et al. The optimal therapy of calcineurin inhibitors for pregnancy in kidney transplantation[J]. Clin Transplant, 2015, 29(2):142-148. doi: 10.1111/ctr.12494 URL
[39]	Flint J, Panchal S, Hurrell A, et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breast feeding-Part Ⅰ: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids[J]. Rheumatology(Oxford), 2016, 55(9):1693-1697. doi: 10.1093/rheumatology/kev404 URL
[40]	Sanchez-Gonzalez LR, Castro-Melendez SE, Angeles-Torres AC, et al. Efficacy and safety of adjuvant recombinant human erythropoietin and ferrous sulfate as treatment for iron deficiency anemia during the third trimester of pregnancy[J]. Eur J Obstet Gynecol Reprod Biol, 2016, 205:32-36. doi: 10.1016/j.ejogrb.2016.08.004 pmid: 27566219
[41]	Tariq N, Ayub R, Khan WU, et al. Parenteral iron therapy in the treatment of iron deficiency anemia during pregnancy: a randomized controlled trial[J]. J Coll Physicians Surg Pak, 2015, 25(3):193-197.
[42]	Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia[J]. N Engl J Med, 2017, 377(7):613-622. doi: 10.1056/NEJMoa1704559 URL
[43]	Wiles KS, Nelson-Piercy C, Bramham K. Reproductive health and pregnancy in women with chronic kidney disea-se[J]. Nat Rev Nephrol, 2018, 14(3):165-184. doi: 10.1038/nrneph.2017.187 pmid: 29355168
[44]	van Dorp W, Mulder RL, Kremer LC, et al. Recommendations for premature ovarian insufficiency surveillance for female survivors of childhood, adolescent, and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup consortium[J]. J Clin Oncol 2016, 34(28): 3440-3450. doi: 10.1200/JCO.2015.64.3288 URL
[45]	Donnez J, Dolmans MM. Fertility preservation in women[J]. N Engl J Med, 2017, 377(17):1657-1665. doi: 10.1056/NEJMra1614676 URL

慢性肾脏病患者妊娠的管理现状及策略

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 45

相关文章 15

编辑推荐

Metrics

本文评价

[1]	宋洛卿, 戴廷军. 原发性抗磷脂综合征合并烟雾综合征一例并文献复习[J]. 诊断学理论与实践, 2022, 21(04): 497-503.
[2]	郝旭, 王伟铭. 依靠肾活检确诊的以肾脏病变为主要表现的法布里病1例报告[J]. 诊断学理论与实践, 2022, 21(04): 527-529.
[3]	杜燕然, 焦景, 任芸芸, 周建桥. 超声影像组学技术在评估胎肺成熟度中的应用[J]. 诊断学理论与实践, 2022, 21(03): 326-330.
[4]	曹云云, 王冠杰, 曾敏, 王海飞, 牛建梅, 周雷平. 早孕期超声相关参数预测胚胎妊娠结局价值的分析[J]. 诊断学理论与实践, 2021, 20(05): 445-449.
[5]	范秋灵. 糖尿病肾病和非糖尿病慢性肾脏病患者应用钠-葡萄糖协同转运蛋白2抑制剂：预后评估及相关指南解读[J]. 诊断学理论与实践, 2021, 20(02): 130-137.
[6]	吴萍, 冯炜炜. 剖宫产瘢痕妊娠的临床管理及继续妊娠的探究[J]. 诊断学理论与实践, 2020, 19(1): 95-99.
[7]	左广民, 彭魁, 李勉, 徐敏, 毕宇芳, 宁光. 上海社区中老年人群脂肪肝指数与微量白蛋白尿的相关性研究[J]. 诊断学理论与实践, 2020, 19(06): 605-609.
[8]	余舒文, 方正滢, 谢静远. 基因检测在慢性肾脏病诊治中的应用及进展[J]. 诊断学理论与实践, 2020, 19(06): 613-617.
[9]	李贵森. 2019年《中国慢性肾脏病矿物质和骨异常诊治指南》解读[J]. 诊断学理论与实践, 2020, 19(03): 229-231.
[10]	林建华, 缪慧娴. 妊娠合并心脏病的分类诊断和妊娠风险评估[J]. 诊断学理论与实践, 2019, 18(06): 613-618.
[11]	姚小艳, 陈君. 上海地区孕妇维生素D水平调查及其与妊娠期糖尿病发生的相关性研究及其预测价值探索[J]. 诊断学理论与实践, 2019, 18(06): 634-639.
[12]	王媛媛, 范秋灵. 血清降钙素原在慢性肾脏病合并细菌感染患者中的临床价值[J]. 诊断学理论与实践, 2019, 18(03): 353-359.
[13]	黄亚, 徐利, 葛凤菊, 吴鋆龙, 陈亚宁, 祁秀娟. 激光辅助孵化完全去除透明带对冷冻单囊胚移植结局的影响[J]. 诊断学理论与实践, 2019, 18(03): 334-339.
[14]	叶岚, 张欢, 钱朝霞. 磁共振在异位妊娠中的影像表现及临床价值[J]. 诊断学理论与实践, 2017, 16(06): 650-655.
[15]	韩晓凤, 方怡, 朱坚轶, 黄洪晖, 陈芳源. 以反复流产为表现的阵发性睡眠性血红蛋白尿一例[J]. 诊断学理论与实践, 2017, 16(04): 430-431.